Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to $2.0 million.

  • Milestone Scientific's Accounts Payables rose 7686.83% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 7686.83%. This contributed to the annual value of $1.0 million for FY2024, which is 4811.3% up from last year.
  • As of Q3 2025, Milestone Scientific's Accounts Payables stood at $2.0 million, which was up 7686.83% from $1.5 million recorded in Q2 2025.
  • Over the past 5 years, Milestone Scientific's Accounts Payables peaked at $2.0 million during Q3 2025, and registered a low of $120000.0 during Q1 2022.
  • Moreover, its 5-year median value for Accounts Payables was $1.1 million (2022), whereas its average is $1.1 million.
  • Per our database at Business Quant, Milestone Scientific's Accounts Payables tumbled by 8271.0% in 2022 and then soared by 58658.92% in 2023.
  • Quarter analysis of 5 years shows Milestone Scientific's Accounts Payables stood at $780428.0 in 2021, then soared by 41.3% to $1.1 million in 2022, then crashed by 37.46% to $689604.0 in 2023, then skyrocketed by 48.11% to $1.0 million in 2024, then surged by 97.07% to $2.0 million in 2025.
  • Its Accounts Payables stands at $2.0 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.9 million for Q1 2025.